SEC Form 4 · accession 0001209191-15-071764
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Blaine Templeman
Officer — Executive VP, General Counsel
Period of report
Sep 18, 2015
Accepted (ET)
Sep 22, 2015 · 12:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $23.72 | Sep 18, 2015 | A | 200,000 | A | — | Sep 18, 2025 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.